ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,679Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 96

$2.03M Total Retail Price of All Prescriptions

Rank: 2 out of 96

806 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 806 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

5% of this provider’s 806 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 25,232 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
NAMENDA 1,152 1,147 1 11
LEVOTHYROXINE SODIUM 930 897 2 3
DONEPEZIL HCL 825 825 3 8
SIMVASTATIN 792 782 4 1
OMEPRAZOLE 782 782 5 5
AMLODIPINE BESYLATE 650 645 6 2
FUROSEMIDE 643 642 7 4
SERTRALINE HCL 629 629 8 15
EXELON 514 514 9 47
METOPROLOL SUCCINATE 483 483 10 9
LISINOPRIL 443 441 11 10
MIRTAZAPINE 437 424 12 14
WARFARIN SODIUM 410 399 13 6
ESCITALOPRAM OXALATE 393 388 14 24
ATORVASTATIN CALCIUM 332 318 15 12
METOPROLOL TARTRATE 298 286 16 7
FAMOTIDINE 289 278 17 21
METFORMIN HCL 252 252 18 13
ALENDRONATE SODIUM 240 240 19 36
LIDODERM 231 228 20 45
ZOLPIDEM TARTRATE 227 227 21 18
ADVAIR DISKUS 219 219 22 46
DIOVAN 213 199 23 17
SPIRIVA 213 213 23 67
POTASSIUM CHLORIDE 212 212 25 19
BYSTOLIC 204 204 26 56
CARVEDILOL 189 174 27 22
HYDROCHLOROTHIAZIDE 180 180 28 16
PRADAXA 178 178 29 150
ENABLEX 177 177 30 100
CYMBALTA 176 176 31 51
CARBIDOPA-LEVODOPA 174 174 32 48
TAMSULOSIN HCL 171 171 33 29
SPIRONOLACTONE 169 169 34 70
OLANZAPINE 167 155 35 76
QUETIAPINE FUMARATE 166 166 36 32
RISPERIDONE 166 166 36 31
DILTIAZEM 24HR CD 162 162 38 83
LYRICA 161 152 39 73
GABAPENTIN 156 145 40 20
POLYETHYLENE GLYCOL 3350 156 156 40 53
DIGOXIN 156 156 40 34
CLOPIDOGREL 156 156 40 27
AZITHROMYCIN 151 147 44 54
OXYCODONE-ACETAMINOPHEN 150 149 S2 45 26
LOSARTAN POTASSIUM 142 142 46 23
GALANTAMINE HBR 142 142 46 117
TRAMADOL HCL 136 134 48 35
ARICEPT 136 136 48 160
MELOXICAM 128 128 50 65
FLUTICASONE PROPIONATE 127 127 51 55
JANUVIA 126 126 52 49
PLAVIX 125 125 53 42
PANTOPRAZOLE SODIUM 125 123 53 44
GLIPIZIDE 123 123 55 62
PREDNISONE 111 111 56 58
PAROXETINE HCL 107 94 57 66
ATENOLOL 106 106 58 30
METHENAMINE HIPPURATE 106 106 58 199
CIPROFLOXACIN HCL 104 104 60 97
TRAZODONE HCL 103 87 61 38
LEXAPRO 96 96 62 92
BUMETANIDE 96 96 62 157
ABILIFY 93 93 64 122
HYDROCODONE-ACETAMINOPHEN 89 74 S3 65 52
IPRATROPIUM-ALBUTEROL 87 87 66 57
DIVALPROEX SODIUM 86 86 67 41
BUSPIRONE HCL 86 86 67 116
AMIODARONE HCL 86 86 67 103
ENALAPRIL MALEATE 86 86 67 28
NUEDEXTA 84 84 71 90
NYSTATIN 84 83 71 86
CITALOPRAM HBR 83 83 73 25
ALLOPURINOL 83 83 73 82
FINASTERIDE 83 83 73 85
KLOR-CON M20 81 77 76 91
LOPERAMIDE 79 78 77 159
VESICARE 79 79 77 121
NITROGLYCERIN PATCH 78 78 79 89
LEVETIRACETAM 77 64 80 61
RAMIPRIL 76 76 81 69
CHOLESTYRAMINE 75 75 82 222
ISOSORBIDE MONONITRATE ER 73 73 83 60
NOVOLOG FLEXPEN 71 44 84 93
SYNTHROID 69 69 85 99
PRAVASTATIN SODIUM 68 68 86 33
SEROQUEL 67 67 87 106
DILTIAZEM HCL 66 66 88 183
METOLAZONE 66 66 88 179
LANTUS SOLOSTAR 64 46 90 87
OXYBUTYNIN CHLORIDE ER 64 64 90 96
LAMOTRIGINE 64 51 90 115
IPRATROPIUM BROMIDE 62 62 93 124
FENOFIBRATE 61 61 94 149
LATANOPROST 60 60 95 77
NITROFURANTOIN MONO-MACRO 60 59 95 146
PRANDIN 60 60 95 147
VOLTAREN 59 59 98 131
DOXEPIN HCL 58 58 99 251
FLECTOR 57 57 100 185
VERAPAMIL ER 57 54 100 196
BRIMONIDINE TARTRATE 57 57 100 139
SINGULAIR 57 57 100 78
LEVOFLOXACIN 57 56 100 59
FENTANYL 55 55 S2 105 50
GLIMEPIRIDE 54 54 106 43
FLUOXETINE HCL 54 54 106 107
TORSEMIDE 53 53 108 109
GLIPIZIDE ER 52 52 109 144
CALCITONIN-SALMON 52 52 109 263
TRIAMTERENE-HCTZ 51 46 111 148
LUMIGAN 50 50 112 202
CLONIDINE HCL 50 50 112 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.